Ivaltinostat

DB17118InvestigationalSmall molecule

Ivaltinostat: Overview.

Chemical structure of Ivaltinostat
Mechanism
Curator reviewed
Formula / weight
C24H36N3O8P · 525.539 g/mol (avg)
Also known as
(E)-N-(3-(DIMETHYLAMINO)PROPYL)-N'-HYDROXY-2-((1-NAPHTHYLOXY)METHYL)-2-OCTENEDIAMIDE · 2-OCTENEDIAMIDE, N1-(3-(DIMETHYLAMINO)PROPYL)-N8-HYDROXY-2-((1-NAPHTHALENYLOXY)METHYL)-, (2E)-
Code names
CG-2 · CG-200745 · HDCG-0745 · J3.106.463E

Resolves to

Compound
UNII4I8MLM7L2HCAS936221-33-9
Structure
InChIKeyUOKSXAOZBSWROR-DOELHFPHSA-NSMILESOP(O)(O)=O.CN(C)CCCNC(=O)C(\COC1=C2C=CC=CC2=CC=C1)=C\CCCCC(=O)NO

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Drug interactionStructured to mechanism, not free text
Sign in
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Ivaltinostat, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In